Graphical AbstractThe current situation of subclinical coronary atherosclerosis, CHD, and cholesterol control in women and men with FH.1,10,13 Proposal for equitable and cost-effective LDL-C lowering in FH for both sexes.13–15 ASCVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; FH, familial hypercholesterolaemia; LDL-C, LDL-cholesterol; PCSK9; proprotein convertase subtilisin/kexin type 9; siRNA, small interfering RNA.
No takes yet. Share an insight, caveat, or question.
Raúl D. Santos (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: